Phase 3Active, not recruitingAge-related condition
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation (ATHENA)
Ziltivekimab in Heart Failure, Systemic Inflammation
Novo Nordisk A/S · 673 planned · NCT06200207 · updated 1 Oct 2026